Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 詳細を表示
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...
ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY PR Newswire MINNEAPOLIS, Dec. 10, 2024 Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium MINNEAPOLIS, Dec. 10...
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Nov. 27, 2024 MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.69 | 2.25273260464 | 75.02 | 78.1377 | 72.5222 | 844542 | 75.04557721 | CS |
4 | 0.8325 | 1.09716319067 | 75.8775 | 78.1377 | 69.48 | 729468 | 73.4384126 | CS |
12 | 6.77 | 9.67972547898 | 69.94 | 79.86 | 65.61 | 892371 | 73.00090082 | CS |
26 | -0.49 | -0.634715025907 | 77.2 | 83.62 | 65.61 | 876099 | 74.2352942 | CS |
52 | 5.56 | 7.81447645819 | 71.15 | 85.57 | 61.16 | 984692 | 73.24387491 | CS |
156 | -22.29 | -22.5151515152 | 99 | 113.805 | 51.79 | 780985 | 75.82899568 | CS |
260 | 22.5625 | 41.6685904243 | 54.1475 | 135.9625 | 38.7925 | 554010 | 78.03081332 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約